What potential is there for LSD1 inhibitors to reach approval for AML?

被引：16
|
作者：
Pandey, Manu R. [1 ]
Wang, Eunice S. [1 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Dept Med, Leukemia Serv, Elm & Carlton St, Buffalo, NY 14263 USA
来源：
EXPERT OPINION ON EMERGING DRUGS | 2019年 / 24卷 / 04期
关键词：
LSD1; inhibitor; epigenetic; acute myeloid leukemia; clinical trial; HISTONE DEMETHYLASE; DIFFERENTIATION; LEUKEMIA; EPIGENETICS; COMBINATION; DERIVATIVES; THERAPY; DESIGN; GROWTH;
D O I：
10.1080/14728214.2019.1694001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：205 / 212
页数：8
相关论文
共 50 条
  • [1] Annual review of LSD1/KDM1A inhibitors in 2020
    Fu, Dong-Jun
    Li, Jun
    Yu, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 214
  • [2] Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
    Przespolewski, Amanda
    Wang, Eunice S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (07) : 771 - 780
  • [3] A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors
    Dong, Jianshu
    Pervaiz, Waqar
    Tayyab, Bilal
    Li, Die
    Kang, Lei
    Zhang, Huimin
    Gong, Huimin
    Ma, Xinli
    Li, Jian
    Agboyibor, Clement
    Bi, Yuefeng
    Liu, Hongmin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [4] Targeting LSD1 for acute myeloid leukemia (AML) treatment
    Zhang, Shujing
    Liu, Menghan
    Yao, Yongfang
    Yu, Bin
    Liu, Hongmin
    PHARMACOLOGICAL RESEARCH, 2021, 164
  • [5] Recent advances of LSD1/KDM1A inhibitors for disease therapy
    Zhang, Chaofeng
    Wang, Zhiyuan
    Shi, Yuting
    Yu, Bin
    Song, Yihui
    BIOORGANIC CHEMISTRY, 2023, 134
  • [6] Natural products as LSD1 inhibitors for cancer therapy
    Fang, Yuan
    Yang, Chao
    Yu, Zhiqiang
    Li, Xiaochuan
    Mu, Qingchun
    Liao, Guochao
    Yu, Bin
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (03) : 621 - 631
  • [7] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Fang, Yuan
    Liao, Guochao
    Yu, Bin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [8] Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
    Dai, Xing-Jie
    Liu, Ying
    Xue, Lei-Peng
    Xiong, Xiao-Peng
    Zhou, Ying
    Zheng, Yi-Chao
    Liu, Hong-Min
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (05) : 2466 - 2488
  • [9] Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy
    Duan, Yingchao
    Qin, Wenping
    Suo, Fengzhi
    Zhai, Xiaoyu
    Guan, Yuanyuan
    Wang, Xiaojuan
    Zheng, Yichao
    Liu, Hongmin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (23-24) : 6000 - 6014
  • [10] Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitors
    Xu, Yongtao
    Gao, Yunlong
    Yang, Min
    Wang, Meiting
    Lu, Jiarui
    Wu, Ziqing
    Zhao, Junqiang
    Yu, Yi
    Wang, Chang
    Zhao, Zongya
    Gao, Qinghe
    Duan, Yingchao
    Han, Di
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (17) : 1415 - 1433
12345